Growth Hormone Peptides | The Gillett Health Podcast #31

About this video

Gillett turns to AOD 9604, marketed as a growth-hormone fragment for fat loss without growth hormone’s downsides. He summarizes the development story he reviewed: the fragment was designed to retain lipolysis while avoiding insulin resistance, showed modest short-term weight differences in one trial he cites, but did not sustain results in longer trials. He mocks sweeping claims for joints, mood, lipids and bone, noting some striking results come from animal experiments, and says the form his practice finds more reasonable is topical use, often combined with other cosmetic peptides, because he views systemic benefit as unproven and risk as lower topically.

Key takeaways

• A plausible fragment mechanism does not guarantee durable weight loss in humans
• Short-term trial differences can disappear in longer follow-up, Gillett notes
• Animal joint findings should not be marketed as human benefits
• Route matters: he presents topical cosmetic use as a lower-risk framing than systemic use
• Unnamed peptide blends in skincare frustrate mechanism-based evaluation

Episode details: published March 29, 2023 · 6.7K views · 4:24 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: Peptides For Weight Loss? | The Gillett Health Podcast #31 · Next: Research Peptides | The Gillett Health Podcast #31 →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)